Press release
Neuroendocrine Carcinoma Market to grow at a high 7.7% CAGR
Recently, Future Market Insights has presented value analysis and insights on the various disease types, treatment types and end users associated with the neuroendocrine carcinoma market across key regions in the globe. It has also included an in-depth analysis on the various key players participating in the global neuroendocrine carcinoma market along with key developments taking place during the 2017-2027 timeline. Future Market Insights, in its recent publication titled “Neuroendocrine Carcinoma Market: Global Industry analysis (2012-2016) and Opportunity Assessment (2017-2027)” has covered a holistic angle of the global market for neuroendocrine carcinoma with a detailed market segmentation. This research report also unveils various opportunities, trends, drivers and restraints impacting the growth of the global neuroendocrine carcinoma market. Covering past and present market scenario, the global report also gives justice to the readers’ investment in procuring the research report by giving future market projections for a period of ten years.View complete report: https://www.futuremarketinsights.com/reports/neuroendocrine-carcinoma-market
Global Neuroendocrine Carcinoma Market: Key Future Projections
The global neuroendocrine carcinoma market is anticipated to witness high growth during the period of forecast to reach a valuation of about US$ 2.5 Bn by the end of the forecasted year from an estimate of around US$ 1.5 Mn in 2017. This market is projected to grow at a high 7.7% CAGR throughout the forecast period.
Global Neuroendocrine Carcinoma Market: Key Influencing Aspects
There are several aspects influencing the growth of the neuroendocrine carcinoma market. Few growth pushing aspects include rising awareness campaigns by governments for early detection and treatment, rising number of clinical trials in early phase development, exploring new generation sequencing technologies, increasing partnerships to strengthen product portfolios, identifying new solutions to fight cancer, increasing investments in research and development and quick regulatory approvals prompting use of new therapeutic solutions. Also, high cost associated with the treatment of neuroendocrine carcinoma, high cost of development leading to reduction in the number of players participating in this market and manufacturing challenges adversely impacting the product availability are limiting the growth of the global market for neuroendocrine carcinoma.
A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1278
Global Neuroendocrine Carcinoma Market: Segmental Acumen
The global neuroendocrine carcinoma market is segmented on the basis of disease indication type treatment type, end user and by region.
By region, North America region is expected to be highly attractive for the neuroendocrine carcinoma market. The North America neuroendocrine carcinoma market is anticipated to grow at a significant rate to register the highest estimate by the end of the forecasted year thus leading the global market. Also, Asia Pacific excluding Japan (APEJ) neuroendocrine carcinoma market is projected to grow at the highest pace to register a stellar CAGR of 8.5% throughout the forecast period
By disease indication type, the gastric neuroendocrine tumours segment is the largest segment in terms of market value as well as growth rate. This segment is estimated at a high value of US$ 1.2 Bn by 2027 end followed by the lung neuroendocrine tumours segment, that stands at the second position in the global market
Request Report TOC @ https://www.futuremarketinsights.com/askus/rep-gb-1278
By treatment type, the somatostatin analogs segment is expected to dominate the global market with a high market valuation of a bit more than US$ 1.5 Bn by the end of the forecasted year, growing at a noteworthy growth rate during 2017-2027 timeline
By end user, hospitals segment is anticipated to the largest segment leading the global neuroendocrine carcinoma market with a high CAGR of 8.2% during the period of assessment, owing to high infrastructure investment towards adopting newer detection technologies. The clinics segment also reflects high potential in the years to come
Global Neuroendocrine Carcinoma Market: Competitive Scenario
The global neuroendocrine carcinoma market research report has included key players involved in the market. The SWOT analysis, product portfolio, developments, strategies, key financials and other key details of companies such as Pfizer Inc., Novartis AG, Chiasma Inc., Ipsen, Abbvie Inc., Valeant Pharmaceuticals International Inc., Jubilant Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Advanced Accelerator Applications, Mateon Therapeutics, Inc., Lexicon Pharmaceuticals, Inc., Isotopen Technologien München AGGlobal, Hutchison China MediTech Ltd., Amgen Inc., Celgene Corporation, Mallinckrodt plc., and Dauntless Pharmaceuticals, Inc., is included in this extensive research study.
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuroendocrine Carcinoma Market to grow at a high 7.7% CAGR here
News-ID: 1091370 • Views: …
More Releases from Future Market Insights

Carbon-Free Waste Gas Abatement System Market to Grow USD 360.5 million by 2035, …
The global carbon-free waste gas abatement system market is poised for impressive growth, projected to expand from USD 137.7 million in 2025 to USD 360.5 million by 2035, reflecting a robust CAGR of 10.1%. As industries worldwide embrace sustainability, this market is emerging as a critical component of environmental responsibility, catering to both established manufacturers and new entrants seeking to leverage zero-carbon technologies.
Market Momentum and Drivers
From 2021 to 2025, the…

Twist Up Stick Container Market to reach USD 2.9 Billion by 2035 Amid Innovation …
The global Twist Up Stick Container Market is poised for dynamic growth, projected to nearly double in value from USD 1.4 billion in 2025 to USD 2.9 billion by 2035, reflecting a healthy CAGR of 7.5% over the next decade. Driven by rising consumer demand for convenient, hygienic, and travel-friendly packaging solutions, this market presents compelling opportunities for investors, emerging companies, and established players seeking to innovate and expand.
Emerging Trends…

Aerospace Fluid Conveyance System Market to Reach USD 4.3 Billion by 2035 with I …
The global Aerospace Fluid Conveyance System Market is witnessing steady growth, driven by the increasing demand for advanced fluid handling solutions across commercial and military aircraft. Valued at USD 3.1 billion in 2025, the market is projected to reach USD 4.3 billion by 2035, registering a healthy CAGR of 3.4%. Both established and emerging manufacturers are actively innovating to meet the evolving needs of the aviation sector.
Market Dynamics and Growth…

Automotive Starter and Alternator Market to Reach USD 45.4 Billion by 2035 Amid …
The global Automotive Starter and Alternator Market is on track for substantial expansion, driven by rapid advancements in vehicle technology and the growing focus on electrification. Valued at USD 29.3 billion in 2025, the market is projected to reach USD 45.4 billion by 2035, registering a CAGR of 4.5% during the forecast period. The growth reflects the automotive industry's continuous evolution toward fuel-efficient and sustainable systems that integrate reliability, performance,…
More Releases for Neuroendocrine
Neuroendocrine Carcinoma Market Massive Growth opportunity Ahead
Introduction
Neuroendocrine carcinoma (NEC) is a rare and aggressive form of cancer that arises from neuroendocrine cells, which are found throughout the body and are responsible for producing hormones. These tumors can occur in various organs, including the lungs, pancreas, liver, and gastrointestinal tract. Due to its often vague and non-specific symptoms, neuroendocrine carcinoma is frequently diagnosed at an advanced stage, making it challenging to treat effectively.
In recent years, however, there…
Rising Neuroendocrine Tumors Fuel Treatment Market Growth Driving Market Acceler …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Neuroendocrine Tumor Treatment Market Size By 2025?
The industry for treating neuroendocrine tumors has witnessed substantial growth in the previous years. The market size is projected to escalate from $2.17 billion in 2024 to $2.4 billion in 2025, with a compound annual growth rate (CAGR)…
Emerging Trends Influencing The Growth Of The Neuroendocrine Tumor Treatment Mar …
The Neuroendocrine Tumor Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Neuroendocrine Tumor Treatment Market Size Expected to Be by 2034?
The market for neuroendocrine tumor treatment has seen a significant expansion in recent years. Projected to grow from a value…
Prominent Neuroendocrine Tumor Treatment Market Trend for 2025: Clinical Trials …
How Are the key drivers contributing to the expansion of the neuroendocrine tumor treatment market?
The neuroendocrine tumor treatment market is forecasted to expand due to the increasing incidence of neuroendocrine tumors. Neuroendocrine tumors, or NETs, are rare growths that begin in neuroendocrine cells, and their treatment is vital to managing the symptoms, controlling the tumor's growth, and applying radiation therapy to destroy the cancerous cells. The American Society of Clinical…
Neuroendocrine Tumor Treatment Market – Forecast to 2026
According to a new market research report published by Global Market Estimates, the Global Neuroendocrine Tumor Treatment Market is projected to grow from USD 1.8 billion in 2021 to USD 2.1 billion by 2026 at a CAGR value of 5.7% between 2021 to 2026. High prevalence of neuropsychiatric malignancy, awareness regarding early cancer diagnosis, and an increasing number of government initiatives, the neuroendocrine tumor therapy market is expected to rise…
Neuroendocrine Cancer Market: Rising Prevalence of Neuroendocrine Cancer and Gro …
The market report titled ‘Global Neuroendocrine Cancer Market - Size, Share and Forecast (2019 - 2026)’ produced by DataM Intelligence analyses the industry dynamics in this competitive space to provide a comprehensive analysis of the market opportunities.
Neuroendocrine Cancer Market Segmentation Analysis
Total Neuroendocrine Cancer Studies: 2499
By Drug Type
Everolimus
Sunitinib Malate
Lanreotide
Octreotide
Others
Sunitinib (Sutent) and Everolimus (Afinitor) are two major targeted drugs that are being used for the treatment of…